Indication
Radiation Retinopathy
3 clinical trials
4 products
Product
Episcleral CelecoxibClinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Celecoxib Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Product
Episcleral DexamethasoneClinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-09-30
Clinical trial
A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation RetinopathyStatus: Recruiting, Estimated PCD: 2026-11-26
Product
FaricimabProduct
Fluocinolone acetonide